A clinical trial led by the University of Texas’ MD Anderson Cancer Center and the University of Edinburgh’s Nicola Murray Centre for Ovarian Cancer Research (part of the CRUK Edinburgh Centre) tested trametinib, a melanoma drug, and found that it showed promise for...